• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸尿症饮食管理的病例回顾

Case-based review of dietary management of cystinuria.

作者信息

Ucmak Harun, Sonmez Mehmet Giray, Guven Selcuk

机构信息

Department of Urology, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.

出版信息

World J Urol. 2023 May;41(5):1215-1220. doi: 10.1007/s00345-022-04263-1. Epub 2022 Dec 24.

DOI:10.1007/s00345-022-04263-1
PMID:36565321
Abstract

PURPOSE

The currently recommended treatment strategy for cystine stone formers is based on a progressive approach that starts with the most conservative measures. In patients with cystinuria, increased patient compliance with dietary management and medical treatment is associated with fewer stone interventions. In this case-based review, the dietary management of cystine stone former was reviewed under the guidance of evidence-based medicine.

METHODS

The dietary management of the 13-year-old cystinuria patient, who underwent 18 endourological stone interventions, was reviewed in the light of evidence-based medicine. A literature search was performed in Pubmed, MEDLINE, Embase, and Cochrane Library databases according to PRISMA guidelines published from 1993 to September 2022. A total of 304 articles were included in this paper.

RESULTS

In managing patients with cystinuria, hyperhydration, and alkalinization of the urine with medical treatment, the rational use of cystine-binding drugs by taking into account individual situations has come to the fore. A limited study has argued that a vegetarian diet is effective as the alkaline load from fruits and vegetables can reduce the amount of alkalizing substances required to achieve urinary alkalinization above pH 7.5, making it particularly suitable for the dietary treatment of cystine stone disease.

CONCLUSION

Life-long follow-up with dietary modification, hyperhydration, and personalized medical therapy (alkalinization and cystine-binding drugs) are critical in preventing chronic kidney disease and kidney failure in cystinuria.

摘要

目的

目前推荐的胱氨酸结石患者治疗策略基于一种渐进式方法,该方法从最保守的措施开始。在胱氨酸尿症患者中,患者对饮食管理和药物治疗的依从性提高与更少的结石干预相关。在本病例回顾中,在循证医学的指导下对胱氨酸结石患者的饮食管理进行了回顾。

方法

根据1993年至2022年9月发布的PRISMA指南,在Pubmed、MEDLINE、Embase和Cochrane图书馆数据库中进行文献检索,对一名接受了18次腔内泌尿外科结石干预的13岁胱氨酸尿症患者的饮食管理进行循证医学回顾。本文共纳入304篇文章。

结果

在管理胱氨酸尿症患者时,通过药物治疗进行尿液过度水化和碱化,根据个体情况合理使用胱氨酸结合药物已成为关键。一项有限的研究认为,素食饮食是有效的,因为水果和蔬菜中的碱性负荷可以减少将尿液碱化至pH 7.5以上所需的碱化物质的量,使其特别适合胱氨酸结石病的饮食治疗。

结论

通过饮食调整、过度水化和个性化药物治疗(碱化和胱氨酸结合药物)进行终身随访对于预防胱氨酸尿症患者的慢性肾病和肾衰竭至关重要。

相似文献

1
Case-based review of dietary management of cystinuria.胱氨酸尿症饮食管理的病例回顾
World J Urol. 2023 May;41(5):1215-1220. doi: 10.1007/s00345-022-04263-1. Epub 2022 Dec 24.
2
Durability of the medical management of cystinuria.胱氨酸尿症药物治疗的持久性。
J Urol. 2003 Jan;169(1):68-70. doi: 10.1016/S0022-5347(05)64037-2.
3
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
4
How should patients with cystine stone disease be evaluated and treated in the twenty-first century?在21世纪,胱氨酸结石病患者应如何进行评估和治疗?
Urolithiasis. 2016 Feb;44(1):65-76. doi: 10.1007/s00240-015-0841-x. Epub 2015 Nov 27.
5
Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement.胱氨酸肾病结石患者的评估和医学管理:共识声明。
J Endourol. 2020 Nov;34(11):1103-1110. doi: 10.1089/end.2019.0703. Epub 2020 Apr 6.
6
[Clinical study on cystinuria in children--the stone management and the prevention of calculi recurrence].儿童胱氨酸尿症的临床研究——结石处理与预防结石复发
Nihon Hinyokika Gakkai Zasshi. 1998 Sep;89(9):758-65. doi: 10.5980/jpnjurol1989.89.758.
7
The Impact of Diet on Urinary Risk Factors for Cystine Stone Formation.饮食对胱氨酸结石形成的尿危险因素的影响。
Nutrients. 2021 Feb 6;13(2):528. doi: 10.3390/nu13020528.
8
Pharmacological interventions for the management of cystinuria: a systematic review.用于胱氨酸尿症管理的药物干预措施:一项系统评价
J Nephrol. 2024 Mar;37(2):293-308. doi: 10.1007/s40620-023-01795-6. Epub 2023 Nov 13.
9
Staghorn cystine stone in a 72-year-old recurrent calcium stone former.一名72岁复发性钙结石患者的鹿角形胱氨酸结石。
Clin Nephrol. 2012 Jul;78(1):76-80. doi: 10.5414/cn107046.
10
Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.儿童及青少年胱氨酸尿症:诊断、治疗及随访建议
Pediatr Nephrol. 2005 Jan;20(1):19-24. doi: 10.1007/s00467-004-1663-1. Epub 2004 Nov 25.

引用本文的文献

1
En bloc resection of bladder tumors (ERBT) revisited 12 years after reintroduction: too good to be further ignored.再次回顾整块膀胱肿瘤切除术(ERBT):12 年后重新引入,好得不容忽视。
World J Urol. 2023 Oct;41(10):2577-2582. doi: 10.1007/s00345-023-04629-z.

本文引用的文献

1
Cystinuria: Review of a Life-long and Frustrating Disease.胱氨酸尿症:一种终身且令人沮丧的疾病综述。
Yale J Biol Med. 2021 Dec 29;94(4):681-686. eCollection 2021 Dec.
2
Non-contrast computed tomography characteristics in a large cohort of cystinuria patients.胱氨酸尿症患者大队列的非对比计算机断层扫描特征。
World J Urol. 2021 Jul;39(7):2753-2757. doi: 10.1007/s00345-020-03509-0. Epub 2020 Nov 9.
3
Cystinuria: clinical practice recommendation.胱氨酸尿症:临床实践建议。
Kidney Int. 2021 Jan;99(1):48-58. doi: 10.1016/j.kint.2020.06.035. Epub 2020 Sep 9.
4
Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.与胱氨酸尿症目前使用的医学治疗方法相关的不良事件和治疗目标:来自法国 442 例患者的一系列结果。
BJU Int. 2019 Nov;124(5):849-861. doi: 10.1111/bju.14721. Epub 2019 Mar 25.
5
Nephrolithiasis and Nephrocalcinosis in Childhood-Risk Factor-Related Current and Future Treatment Options.儿童肾结石和肾钙质沉着症——与风险因素相关的当前及未来治疗选择
Front Pediatr. 2018 Apr 12;6:98. doi: 10.3389/fped.2018.00098. eCollection 2018.
6
Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1.肾近端小管中的新型胱氨酸转运体被鉴定为与胱氨酸尿症相关的质膜蛋白rBAT/SLC3A1缺失的伙伴。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):775-80. doi: 10.1073/pnas.1519959113. Epub 2016 Jan 6.
7
How should patients with cystine stone disease be evaluated and treated in the twenty-first century?在21世纪,胱氨酸结石病患者应如何进行评估和治疗?
Urolithiasis. 2016 Feb;44(1):65-76. doi: 10.1007/s00240-015-0841-x. Epub 2015 Nov 27.
8
Cystinuria: current diagnosis and management.胱氨酸尿症:当前的诊断与管理。
Urology. 2014 Apr;83(4):693-9. doi: 10.1016/j.urology.2013.10.013. Epub 2013 Nov 16.
9
Update on cystinuria.胱氨酸尿症的最新进展。
Curr Opin Nephrol Hypertens. 2013 Jul;22(4):427-31. doi: 10.1097/MNH.0b013e3283621c5d.
10
Optimum nutrition for kidney stone disease.肾结石病的最佳营养。
Adv Chronic Kidney Dis. 2013 Mar;20(2):165-74. doi: 10.1053/j.ackd.2012.12.001.